Cyclophosphamide5q deletion myelodysplastic syndrome: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1647卷 / 1期
关键词：
D O I：
10.1007/s40278-017-28793-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：101 / 101
相关论文
共 50 条
  • [41] 2 KARYOTYPICALLY UNRELATED CLONES WITH THE T(5, 17) AND DELETION OF 5Q IN MYELODYSPLASTIC SYNDROME
    NOVAK, A
    JANKOVIC, G
    ROLOVIC, Z
    CANCER GENETICS AND CYTOGENETICS, 1992, 62 (01) : 100 - 102
  • [42] Myelodysplastic syndrome in a child with 15q24 deletion syndrome
    Narumi, Yoko
    Shiohara, Masaaki
    Wakui, Keiko
    Hama, Asahito
    Kojima, Seiji
    Yoshikawa, Kentaro
    Amano, Yoshiro
    Kosho, Tomoki
    Fukushima, Yoshimitsu
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2012, 158A (02) : 412 - 416
  • [43] 5q duplication and 13q deletion in a patient with Fanconi anemia associated with Myelodysplastic syndrome
    Bennour, H. Sennana
    Omri, H. E. L.
    Khelif, A.
    Saad, A.
    CHROMOSOME RESEARCH, 2007, 15 : 218 - 219
  • [44] Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion
    Feurstein, Simone
    Thomay, Kathrin
    Hofmann, Winfried
    Buesche, Guntram
    Kreipe, Hans
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Schlegelberger, Brigitte
    Goehring, Gudrun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [45] COST SAVINGS ASSOCIATED WITH TRANSFUSION INDEPENDENCE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH A 5Q-DELETION
    Bozkaya, D.
    Mahmoud, D.
    Mitsi, G.
    Khan, Z. M.
    VALUE IN HEALTH, 2011, 14 (03) : A160 - A160
  • [46] Isolated deletion of 6q in a patient with myelodysplastic syndrome
    Gozzetti, Alessandro
    Crupi, Rosaria
    Defina, Marzia
    Bocchia, Monica
    Raspadori, Donatella
    Lauria, Francesco
    CANCER GENETICS AND CYTOGENETICS, 2009, 192 (01) : 51 - 51
  • [47] The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q
    Dawn Lee
    Nic Brereton
    Sujith Dhanasiri
    Austin Kulasekararaj
    PharmacoEconomics - Open, 2019, 3 : 351 - 358
  • [48] The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q
    Lee, Dawn
    Brereton, Nic
    Dhanasiri, Sujith
    Kulasekararaj, Austin
    PHARMACOECONOMICS-OPEN, 2019, 3 (03) : 351 - 358
  • [49] 18q deletion syndrome: A case report and review of the literature
    Verhoeven, W
    Van Ravenswaay, C
    EUROPEAN PSYCHIATRY, 2005, 20 : S10 - S10
  • [50] Case report of a novel phenotype in 18q deletion syndrome
    Bohiltea, Roxana Elena
    Cirstoiu, Monica Mihaela
    Nedelea, Florina Mihaela
    Turcan, Natalia
    Georgescu, Tiberiu Augustin
    Munteanu, Octavian
    Baros, Alexandru
    Istrate-Ofiteru, Anca Maria
    Berceanu, Costin
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2020, 61 (03): : 905 - 910
12345